Who Supplies Carfilzomib? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Carfilzomib exports, with 65+ registered manufacturers shipping to buyers across 47+ countries — yet a handful of companies dominate the shipments. MSN LABORATORIES PRIVATE LIMITED holds the largest share at 60.7% (export value: $737.1K). Close behind, SARTAJ PHARMA PRIVATE LIMITED (7.5%, $90.8K). NATCO PHARMA LIMITED (4.4%, $53.3K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Carfilzomib? Top Manufacturers & Their Buyers
Flow of Carfilzomib from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Carfilzomib Supplier Network — Key Market Intelligence
The Carfilzomib export market from India is led by MSN LABORATORIES PRIVATE LIMITED, which alone commands a 60.7% share, shipping $737.1K worth of product across 19 shipments. The second-largest exporter, SARTAJ PHARMA PRIVATE LIMITED, contributes $90.8K (7.5%) to the overall market. Combined, the top two suppliers alone account for 68.2% of all Carfilzomib exports, indicating a relatively concentrated supply base.
Across all 65 tracked manufacturers, the total Carfilzomib export value stands at $1.2M from 203 shipments. The market average shipment value is $6.0K. The single largest buyer relationship in terms of trade value is OOO"JODAS EXPOIM", receiving $737.1K worth of product.
The combined buyer network spans 12 named purchasing companies, including OOO"JODAS EXPOIM", MSN LABS CHILE SPARU, MSN LABS BRASIL LTDA, SAFE LAB LOGISTICS S, SANDOZ DO BRASIL IND and 7 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the first-largest Carfilzomib exporter from India, with a market share of 60.7% and a total export value of $737.1K across 19 shipments. Their average shipment value of $38.8K is above the market average of $6.0K, suggesting premium or bulk contract pricing.
MSN LABORATORIES PRIVATE LIMITED serves 1 named buyer in our database. OOO"JODAS EXPOIM" is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• OOO"JODAS EXPOIM" — $737.1K across 19 shipments (100.0% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED's per-shipment value of $38.8K is 549% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.
2SARTAJ PHARMA PRIVATE LIMITED
SARTAJ PHARMA PRIVATE LIMITED is the second-largest Carfilzomib exporter from India, with a market share of 7.5% and a total export value of $90.8K across 7 shipments. Their average shipment value of $13.0K is above the market average of $6.0K, suggesting premium or bulk contract pricing.
SARTAJ PHARMA PRIVATE LIMITED serves 5 named buyers in our database. MSN LABS CHILE SPARU is the dominant customer, accounting for 98.8% of this supplier's tracked business. Top customers include:
• MSN LABS CHILE SPARU — $89.7K across 7 shipments (98.8% of this supplier's total exports)
• MSN LABS BRASIL LTDA — $484 across 0 shipments (0.5% of this supplier's total exports)
• SAFE LAB LOGISTICS S — $253 across 0 shipments (0.3% of this supplier's total exports)
• SANDOZ DO BRASIL IND — $240 across 0 shipments (0.3% of this supplier's total exports)
• SANDOZ DO BRASIL IND — $158 across 0 shipments (0.2% of this supplier's total exports)
Key Insight: SARTAJ PHARMA PRIVATE LIMITED's per-shipment value of $13.0K is 117% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.
3NATCO PHARMA LIMITED
NATCO PHARMA LIMITED is the third-largest Carfilzomib exporter from India, with a market share of 4.4% and a total export value of $53.3K across 7 shipments. Their average shipment value of $7.6K is above the market average of $6.0K, suggesting premium or bulk contract pricing.
NATCO PHARMA LIMITED serves 1 named buyer in our database. ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA — $53.3K across 7 shipments (100.0% of this supplier's total exports)
Key Insight: NATCO PHARMA LIMITED's per-shipment value of $7.6K is 27% above the market average of $6.0K, consistent with large-order contracts or value-added formulations.
43S CORPORATION
3S CORPORATION is the fourth-largest Carfilzomib exporter from India, with a market share of 2.7% and a total export value of $32.9K across 8 shipments. Their average shipment value of $4.1K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.
3S CORPORATION serves 3 named buyers in our database. RAFTAR MARIME FZE is the dominant customer, accounting for 58.3% of this supplier's tracked business. Top customers include:
• RAFTAR MARIME FZE — $19.2K across 5 shipments (58.3% of this supplier's total exports)
• SARTAJ ENTERPRIESES — $11.7K across 3 shipments (35.6% of this supplier's total exports)
• TO THE ORDER OF THE — $2.0K across 0 shipments (6.1% of this supplier's total exports)
Key Insight: 3S CORPORATION operates with high shipment frequency (8 shipments) at a per-shipment value of $4.1K, indicating a broad distribution network with many smaller, regular orders.
5MBA PHARMACEUTICALS PRIVATE LIMITED
MBA PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Carfilzomib exporter from India, with a market share of 2.1% and a total export value of $25.7K across 13 shipments. Their average shipment value of $2.0K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.
MBA PHARMACEUTICALS PRIVATE LIMITED serves 4 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• FOR THE ORDER OF — $12.8K across 6 shipments (49.8% of this supplier's total exports)
• FOR THE ORDER OF — $5.4K across 3 shipments (21.0% of this supplier's total exports)
• M S FOR THE ORDER OF — $5.1K across 3 shipments (19.9% of this supplier's total exports)
• FOR THE ORDER OF — $2.4K across 1 shipments (9.3% of this supplier's total exports)
Key Insight: MBA PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (13 shipments) at a per-shipment value of $2.0K, indicating a broad distribution network with many smaller, regular orders.
6RGSK CANADA HEALTHCARE INC.
RGSK CANADA HEALTHCARE INC. is the fifth-largest Carfilzomib exporter from India, with a market share of 2.1% and a total export value of $25.0K across 7 shipments. Their average shipment value of $3.6K is below the market average of $6.0K, reflecting a high-volume, competitive pricing strategy.
RGSK CANADA HEALTHCARE INC. serves 3 named buyers in our database. EVEREST BANK LTD is the dominant customer, accounting for 77.7% of this supplier's tracked business. Top customers include:
• EVEREST BANK LTD — $19.5K across 5 shipments (77.7% of this supplier's total exports)
• EVEREST BANK LIMITED — $3.5K across 1 shipments (13.9% of this supplier's total exports)
• D K M PHARMACEUTICAL — $2.1K across 1 shipments (8.3% of this supplier's total exports)
Key Insight: RGSK CANADA HEALTHCARE INC. operates with high shipment frequency (7 shipments) at a per-shipment value of $3.6K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Carfilzomib Flows
Once Carfilzomib leaves the manufacturing plants of companies like MSN LABORATORIES PRIVATE LIMITED and SARTAJ PHARMA PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $1.2M. Russia absorbs the largest share at 60.7% ($737.1K), followed by Chile (7.4%) and Ecuador (4.4%).
This geographic spread reflects Carfilzomib's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Carfilzomib Go? Top Importing Countries & Their Buyers
Trade flow of Carfilzomib exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Carfilzomib imports from India, with a total trade value of $737.1K across 0 shipments — representing a 60.7% share of all Carfilzomib exports. The average shipment value of $737.1K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Russia's per-shipment average of $737.1K (12231% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Carfilzomib imports from India.
2Chile
Chile ranks as the second-largest destination for Carfilzomib imports from India, with a total trade value of $89.7K across 0 shipments — representing a 7.4% share of all Carfilzomib exports. The average shipment value of $89.7K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Chile's per-shipment average of $89.7K (1400% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Chile is a key market for Carfilzomib imports from India.
3Ecuador
Ecuador ranks as the third-largest destination for Carfilzomib imports from India, with a total trade value of $53.3K across 2 shipments — representing a 4.4% share of all Carfilzomib exports. The average shipment value of $26.6K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carfilzomib importers in Ecuador: ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the largest buyer, accounting for 100.0% ($53.3K) of this market's total imports.
• ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA — $53.3K (100.0% of Ecuador's total)
Key Insight: Ecuador's per-shipment average of $26.6K (346% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ecuador is a key market for Carfilzomib imports from India.
4United Arab Emirates
United Arab Emirates ranks as the fourth-largest destination for Carfilzomib imports from India, with a total trade value of $48.9K across 4 shipments — representing a 4.0% share of all Carfilzomib exports. The average shipment value of $12.2K is above the global average of $6.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Carfilzomib importers in United Arab Emirates: RAFTAR MARIME FZE is the largest buyer, accounting for 39.2% ($19.2K) of this market's total imports.
• RAFTAR MARIME FZE — $19.2K (39.2% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $12.2K (104% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Carfilzomib imports from India.
5Armenia
Armenia ranks as the fifth-largest destination for Carfilzomib imports from India, with a total trade value of $43.1K across 8 shipments — representing a 3.5% share of all Carfilzomib exports. The average shipment value of $5.4K is below the global average of $6.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Carfilzomib importers in Armenia: VLADIMIR GASPARYAN is the largest buyer, accounting for 53.8% ($23.2K) of this market's total imports.
• VLADIMIR GASPARYAN — $23.2K (53.8% of Armenia's total)
• VLADIMIR GASPARYAN APP — $11.6K (27.0% of Armenia's total)
Key Insight: Armenia receives frequent, smaller shipments of Carfilzomib — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Armenia is a key market for Carfilzomib imports from India.
People Also Ask — Carfilzomib Supplier & Trade Network
Who are the top suppliers of Carfilzomib from India?+
Which companies buy Carfilzomib from Indian manufacturers?+
Where does Carfilzomib exported from India go?+
What is the market share of the top Carfilzomib supplier from India?+
What is the average shipment value for Carfilzomib exports from India?+
Is Carfilzomib manufactured in India and exported globally?+
Which country imports the most Carfilzomib from India?+
Who are the buyers of Carfilzomib in Chile?+
How concentrated is the Carfilzomib supplier market in India?+
How do I find verified buyers for Carfilzomib in specific countries?+
Carfilzomib Trade Network — Key Takeaways
- 1MSN LABORATORIES PRIVATE LIMITED is India's dominant Carfilzomib exporter with a 60.7% market share and $737.1K in total exports — making it the single most important sourcing entity in this market.
- 2The top 65 suppliers collectively account for 79.5% of all tracked Carfilzomib exports, with a combined trade value of $1.2M.
- 3Russia is the largest destination market, absorbing 60.7% of India's Carfilzomib exports ($737.1K). Chile (7.4%) and Ecuador (4.4%) follow.
- 4With 203 total shipments averaging $6.0K each, the Carfilzomib export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include OOO"JODAS EXPOIM", MSN LABS CHILE SPARU, MSN LABS BRASIL LTDA, ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 47 countries
Network value: $1.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carfilzomib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Carfilzomib.
- 2.Flow Mapping: 65 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 203 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 47 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
203 Verified Shipments
65 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists